A Phase I/IIa Clinical Trial to Evaluate Safety and Efficacy of Adipose Tissue-derived Mesenchymal Stem Cells (ASC) on Induction to Remission in Ulcerative Colitis
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Darvadstrocel (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Biomarker
- Acronyms ALOASCU
- 08 Aug 2013 New trial record